DE69629457D1 - Impfstoff in gelform - Google Patents

Impfstoff in gelform

Info

Publication number
DE69629457D1
DE69629457D1 DE69629457T DE69629457T DE69629457D1 DE 69629457 D1 DE69629457 D1 DE 69629457D1 DE 69629457 T DE69629457 T DE 69629457T DE 69629457 T DE69629457 T DE 69629457T DE 69629457 D1 DE69629457 D1 DE 69629457D1
Authority
DE
Germany
Prior art keywords
vaccine
gel form
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629457T
Other languages
English (en)
Other versions
DE69629457T2 (de
Inventor
Eng-Hong Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69629457D1 publication Critical patent/DE69629457D1/de
Publication of DE69629457T2 publication Critical patent/DE69629457T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
DE69629457T 1995-02-21 1996-02-21 Impfstoff in gelform Expired - Lifetime DE69629457T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US390956 1989-08-09
US39095695A 1995-02-21 1995-02-21
PCT/CA1996/000100 WO1996025951A1 (en) 1995-02-21 1996-02-21 Gel form of a vaccine

Publications (2)

Publication Number Publication Date
DE69629457D1 true DE69629457D1 (de) 2003-09-18
DE69629457T2 DE69629457T2 (de) 2004-06-24

Family

ID=23544639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629457T Expired - Lifetime DE69629457T2 (de) 1995-02-21 1996-02-21 Impfstoff in gelform

Country Status (9)

Country Link
EP (1) EP0812213B1 (de)
CN (1) CN1083279C (de)
AU (1) AU701890B2 (de)
BR (1) BR9607462A (de)
CA (1) CA2169987C (de)
DE (1) DE69629457T2 (de)
EA (1) EA002317B1 (de)
ES (1) ES2205014T3 (de)
WO (1) WO1996025951A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2213385A1 (en) * 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
US8912165B2 (en) 1999-03-12 2014-12-16 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
US8501710B2 (en) * 1999-03-12 2013-08-06 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
DE10023401A1 (de) 2000-05-12 2001-11-15 Bayer Ag Formulierung von Mikroorganismen für die Nagertierbekämpfung in Ködergel
CA2464522C (en) * 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
US8858959B2 (en) * 2011-07-15 2014-10-14 The United States Of America, As Represented By The Secretary Of Agriculture Gel vaccine delivery system for treating poultry
BR112014003950B1 (pt) 2011-08-24 2022-01-11 Dupont Nutrition Biosciences Aps. Uso de cepas de bacillus isoladas produtoras de enzima e alimentação de um animal
USRE49477E1 (en) 2012-04-20 2023-03-28 Thomas Jefferson University Engineered antibody for inhibition of fibrosis
WO2017030876A1 (en) * 2015-08-14 2017-02-23 Clearh2O, Inc. High throughput process for delivering semi-firm gel for poultry
EP3434224B1 (de) 2017-07-24 2019-09-04 Erber Aktiengesellschaft Vorrichtung und verfahren zur abgabe von tropfen von flüssigkeiten auf geschlüpfte geflügeljungtiere
CN108926710A (zh) * 2018-06-08 2018-12-04 程金水 一种动物用肠溶口服凝胶疫苗及其制备、使用方法
CN111821464B (zh) * 2020-07-22 2023-08-01 内蒙古农业大学 一种饮水免疫用兔球虫病减毒活疫苗助悬剂及其制备方法
CN114146169B (zh) * 2021-12-28 2023-08-25 佛山市正典生物技术有限公司 鸡球虫喷滴免疫用载体组合物及使用方法和鸡球虫喷滴免疫组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1204057A (en) * 1982-06-22 1986-05-06 Eng-Hong Lee Immunization against coccidiosis
GB8326633D0 (en) * 1983-08-04 1983-11-09 Unilever Plc Compositions

Also Published As

Publication number Publication date
EA002317B1 (ru) 2002-04-25
EA199700127A1 (ru) 1998-02-26
CA2169987A1 (en) 1996-08-22
DE69629457T2 (de) 2004-06-24
EP0812213A1 (de) 1997-12-17
AU4660996A (en) 1996-09-11
CA2169987C (en) 1999-02-02
AU701890B2 (en) 1999-02-11
WO1996025951A1 (en) 1996-08-29
EP0812213B1 (de) 2003-08-13
ES2205014T3 (es) 2004-05-01
BR9607462A (pt) 1997-12-23
CN1083279C (zh) 2002-04-24
CN1181705A (zh) 1998-05-13

Similar Documents

Publication Publication Date Title
BR9610156A (pt) Composição em gel
EE9800042A (et) Inhalaatorites kasutatav seade
DE69523172T2 (de) Einstellbare formmatrix
BR9711853A (pt) Vacinas
DE69629457D1 (de) Impfstoff in gelform
DE69606200T2 (de) Ionenpolymere in tablettenform
DE69613663T2 (de) Einstellbarer Anschlag
DE69601182T2 (de) Silicongelzusammensetzung
DK0863991T3 (da) Antigeniske præparater
DE59603621D1 (de) Leukoindigo-präparationen in granulatform
ITMI950676A0 (it) Vaccini polinucleotidici
DE69522489D1 (de) Haarkräftigungsmittel
KR970016025U (ko) 간격 조절용 책꽂이
DE29503674U1 (de) Zerlegbarer Patienten-Lothublifter in Leichtausführung
BR9503177A (pt) Gel dental
KR970005166A (ko) 다리동작이 용이한 마네킹
KR970011854U (ko) 속치마가 일체로 된 한복
DE29514195U1 (de) Orthopädisch-medizinisches Kopfkissen
ITBO950436A0 (it) Cravatta in mastice siliconico
KR970048309U (ko) 셋탑 유니트에서의 인터페이스 장치
FIU980539U0 (fi) Geelimuotoinen farmaseuttinen valmiste
KR970005245A (ko) 교합기
FR2729990B1 (fr) Equerre reglable
UA1000S (uk) Манікюрний набір
FIU940379U0 (fi) Hopsaettningsmaskin foer lastpallsben

Legal Events

Date Code Title Description
R082 Change of representative

Ref document number: 812213

Country of ref document: EP